Production of PLGA micro- and nanocomposites by supercritical fluid extraction of emulsions: I. Encapsulation of lysozyme

被引:73
作者
Kluge, Johannes [1 ]
Fusaro, Francesco [1 ]
Casas, Nathalie [1 ]
Mazzotti, Marco [1 ]
Muhrer, Gerhard [2 ]
机构
[1] ETH, Inst Proc Engn, CH-8092 Zurich, Switzerland
[2] Novartis Pharma AG, Chem & Analyt Dev, CH-4002 Basel, Switzerland
关键词
Supercritical; SFEE; PLGA; Emulsion; Controlled release; Targeting; SOLVENT EVAPORATION TECHNIQUE; SOLUTION-ENHANCED DISPERSION; DRUG-RELEASE RATE; BIODEGRADABLE MICROPARTICLES; COMPOSITE-PARTICLES; GAS ANTISOLVENT; CARBON-DIOXIDE; DENSE GAS; DELIVERY; PRECIPITATION;
D O I
10.1016/j.supflu.2009.05.010
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Micro- and nanoparticles of bio-compatible and bio-degradable polymers such as poly-lactic-co-glycolic acid (PLGA) are widely used as delivery devices for the administration of sensitive biopharmaceuticals such as proteins, peptides and genes. The purpose of this study is the investigation of supercritical fluid extraction of emulsions (SFEE) as a novel process for the production of such particles. By variation of PLGA concentration and stirring rate during emulsion preparation, particles of pure PLGA with average sizes ranging between 100 nm and a few mu m with very narrow size distributions have been produced in controlled and reproducible manner. Moreover, lysozyme has been used for the formation of composite particles with PLGA. Three different encapsulation methods have been investigated and evaluated by determining the corresponding encapsulation efficiencies. With the method of in situ suspension emulsions, an encapsulation efficiency of up to 48.5% has been achieved. The current study highlights the potential of SFEE as an attractive and scalable process for the manufacturing of drug-PLGA composite particles for pharmaceutical applications. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:327 / 335
页数:9
相关论文
共 38 条
[1]   PLGA microspheres with high drug loading and high encapsulation efficiency prepared by a novel solvent evaporation technique [J].
Bao, Wenchao ;
Zhou, Jiaxiang ;
Luo, Jiufu ;
Wu, Dengxi .
JOURNAL OF MICROENCAPSULATION, 2006, 23 (05) :471-479
[2]   Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method [J].
Barichello, JM ;
Morishita, M ;
Takayama, K ;
Nagai, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (04) :471-476
[3]   PLG microsphere size controls drug release rate through several competing factors [J].
Berkland, C ;
Kim, K ;
Pack, DW .
PHARMACEUTICAL RESEARCH, 2003, 20 (07) :1055-1062
[4]   Precise control of PLG microsphere size provides enhanced control of drug release rate [J].
Berkland, C ;
King, M ;
Cox, A ;
Kim, K ;
Pack, DW .
JOURNAL OF CONTROLLED RELEASE, 2002, 82 (01) :137-147
[5]   Nanoparticles synthesis using supercritical fluid technology - towards biomedical applications [J].
Byrappa, K. ;
Ohara, S. ;
Adschiri, T. .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (03) :299-327
[6]   Drug encapsulation using supercritical fluid extraction of emulsions [J].
Chattopadhyay, P ;
Huff, R ;
Shekunov, BY .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (03) :667-679
[7]   Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process [J].
Cho, M ;
Sah, H .
JOURNAL OF MICROENCAPSULATION, 2005, 22 (01) :1-12
[8]   Operating regimes and mechanism of particle formation during the precipitation of polymers using the PCA process [J].
de Diego, YP ;
Pellikaan, HC ;
Wubbolts, FE ;
Witkamp, GJ ;
Jansens, PJ .
JOURNAL OF SUPERCRITICAL FLUIDS, 2005, 35 (02) :147-156
[9]   APPLICATION OF SUPERCRITICAL FLUIDS FOR THE PRODUCTION OF SUSTAINED DELIVERY DEVICES [J].
DEBENEDETTI, PG ;
TOM, JW ;
YEO, SD ;
LIM, GB .
JOURNAL OF CONTROLLED RELEASE, 1993, 24 (1-3) :27-44
[10]   Particle generation for pharmaceutical applications using supercritical fluid technology [J].
Fages, J ;
Lochard, H ;
Letourneau, JJ ;
Sauceau, M ;
Rodier, E .
POWDER TECHNOLOGY, 2004, 141 (03) :219-226